You can buy or sell Aduro Biotech and other stocks, options, ETFs, and crypto commission-free!
Aduro Biotech, Inc. Common Stock, also called Aduro Biotech, is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Read More Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA.
52 Week High
52 Week Low
— per share
-$0.21 per share